Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:24 AM
Ignite Modification Date:
2025-12-25 @ 2:24 AM
NCT ID:
NCT01868334
Eligibility Criteria:
Practice staff and adults in enrolled clinical sites
Inclusion Criteria:
Site inclusion criteria:
* 1\) an appropriate adult population: e.g., adults aged 50 years and older;
* 2\) currently using an EMR that has prompt ability, such as EpicCare;
* 3\) having and keeping immunization data within this EMR
Patient-level inclusion criteria:
* 1\) Adults (18 years and above) who are active patients of the enrolled practices (e.g., active patients are those with a visit within the last 12 months)
* 2\) All unvaccinated adults without a contraindication are eligible to receive Td/Tdap and influenza, regardless of age and at age 65 years or older are eligible for PPSV.
Exclusion Criteria:
Site exclusion criteria:
* 1\) consistent SOP use for the 3 vaccines being studied or high vaccination rates (e.g., 80%)
Patient-level exclusion criteria:
* 1\) those with a true contraindication, following the CDC's Guide to Contraindications (attached with the US Recommended Adult Immunization Schedule), such as prior vaccine anaphylaxis.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01868334
Study Brief:
Protocol Section:
NCT01868334